In the present study, we evaluated the effects of these stimuli (CTS, IL-1β, and CTS + IL-1β) on the metabolism of human AF cells, as well as possible alterations induced by the treatment with secretome produced by IL-1β–preconditioned MSCs. This evidence concerns the gene IL1B and atrial fibrillation.